3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
111
Neoplasms
22
Neoplasm Metastasis
17
Brain Neoplasms
15
Breast Neoplasms, Male
13
Head and Neck Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Stomach Neoplasms
5
Glioblastoma
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Inflammatory Breast Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Salivary Gland Neoplasms
3
Lung Neoplasms
3
Gliosarcoma
3
Glioma
3
Ependymoma
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Solid Tumors
2
Recurrence
2
Osteitis Deformans
2
Oligodendroglioma
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Interventions
Blood Specimen Collection
13
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
3
Pirinitramide
2
Morphine
2
Bevacizumab
2
ribociclib
1
lanreotide
1
jinfukang
1
eribulin
1
cabazitaxel
1
Zoledronic Acid
1
Vinorelbine
1
Trastuzumab
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Sorafenib
1
Radiofrequency Ablation
1
Propofol
1
Pemetrexed
1
Octreotide
1
Letrozole
1
Lapatinib
1
Injections, Epidural
1
Injections
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplastic Cells, Circulating
×
Lapatinib
×
Clear all
NCT01619111
2024-06-04
DETECT III
University of Ulm
Phase 3
Completed
105 enrolled